High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy

In patients with wild-type transthyretin amyloid cardiomyopathy, hs-cTnI is a strong and independent predictor of mortality. A threshold of hs-cTnI of 80 ng/L for these 3 assays provides effective risk stratification alone and in a staging system with NP.

Authors

Institutions

Publication Details

Journal
Circulation Heart Failure
Published
2025-05-15
DOI
https://doi.org/10.1161/circheartfailure.125.012816
Citations
2
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy

Matteo Serenelli, Stefano Perlini, Alberto Cipriani, Simone Longhi et al.
2 citations
Circulation Heart Failure
Amyloidosis: Diagnosis, Treatment, Outcomes
1.61
article

High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy

Matteo Serenelli, Stefano Perlini, Alberto Cipriani, Simone Longhi, Martina Perazzolo Marra, Teresa Maria Capovilla, Beatrice Musumeci, Roberta Mussinelli, Gianfranco Sinagra, Laura De Michieli, Giuseppe Vergaro, Sabino Iliceto, Alessandro Lupi, Marco Merlo, Giulio Sinigiani, Giacomo Tini, Guido De Sena, Aldostefano Porcari, Allan S. Jaffe, Matteo Bianco, Francesco Cappelli, Giovanni O. Palladini, Paolo Milani, Giulia Saturi, Alessandro Cianca, Gianluigi Guida, Riccardo Albertini, Anna Cantone
article en
2 citations

Abstract

In patients with wild-type transthyretin amyloid cardiomyopathy, hs-cTnI is a strong and independent predictor of mortality. A threshold of hs-cTnI of 80 ng/L for these 3 assays provides effective risk stratification alone and in a staging system with NP.

Circulation Heart FailureVol. 18(8)
University of Padua (IT), Scuola Superiore Sant'Anna (IT), University of Ferrara (IT), University of Pavia (IT), IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT), IRCCS Policlinico San Donato (IT), Amyloidosis Foundation (US), Azienda Ospedaliero-Universitaria Careggi (IT), Azienda USL di Bologna (IT), Mayo Clinic in Arizona (US), Azienda Ospedaliera Sant'Andrea (IT), ERN GUARD-Heart (NL), Policlinico San Matteo Fondazione (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Ospedale San Luigi Gonzaga (IT), Azienda Sanitaria Universitaria Integrata di Trieste (IT)
Good health and well-being
Openalex Percentile: Top 17%
Amyloidosis: Diagnosis, Treatment, Outcomes
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.